Skip to content

The Wide Gap Between What Should Happen and What Actually Happens

The cycle of statins disinformation

Bhavin Jankharia
3 min read
The Wide Gap Between What Should Happen and What Actually Happens
Statin disinformation

Two days, a prominent radiologist, about 4 years my senior, died of a sudden “heart attack”. Perhaps, if he had been on statins, this may have been averted.

In an ideal world, everyone who has a defined ASCVD risk (which we can also calculate on our own), would be on statins. And yet, less than half of those who would benefit, actually land up taking statins. There are many reasons; access to healthcare and affordability are major issues in low middle income countries like India [1], but the other important one is that of “misinformation” [2], especially among those individuals and social groups that can easily afford to take statins and have access to good healthcare.

I guess, I just can’t let go of this issue.

This post is free to read, but you will need to subscribe with your email ID to read the rest of the post.

Related Posts

Members Public

Placebo, Nocebo

The placebo and nocebo effects matter in medicine

Placebo, Nocebo
Members Public

Statins and Dementia

Statins are not associated with an increaed risk of dementia

Statins and Dementia
Members Public

More on the Nocebo Effect of Statins…And With a Sex Bias

More on the nocebo effects of statins including a sex bias

More on the Nocebo Effect of Statins…And With a Sex Bias